I agree that this site is using cookies. You can find further informations here.
X
de Haan, Rosemarie
17  results:
Search for persons X
?
1

Phase I feasibility study of Olaparib in combination with l..:

Navran, Arash ; Al-Mamgani, Abrahim ; Elzinga, Hester...
Clinical and Translational Radiation Oncology.  44 (2024)  - p. 100698 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Practicalities in running early-phase trials using the time..:

van Werkhoven, Erik ; Hinsley, Samantha ; Frangou, Eleni...
BMC Medical Research Methodology.  20 (2020)  1 - p. , 2020
Link: https://doi.org/10.1186/..
 
?
3

Improved pharmacodynamic (PD) assessment of low dose PARP i..:

de Haan, Rosemarie ; Pluim, Dick ; van Triest, Baukelien...
Radiotherapy and Oncology.  126 (2018)  3 - p. 443-449 , 2018
Link: https://doi.org/10.1016/..
 
?
4

Extent of radiosensitization by the PARP inhibitor olaparib..:

Verhagen, Caroline V.M. ; de Haan, Rosemarie ; Hageman, Floor...
Radiotherapy and Oncology.  116 (2015)  3 - p. 358-365 , 2015
Link: https://doi.org/10.1016/..
 
?
5

Retinal Arteriolar Geometry is Associated with Cerebral Whi..:

Doubal, Fergus N. ; de Haan, Rosemarie ; MacGillivray, Thomas J....
International Journal of Stroke.  5 (2010)  6 - p. 434-439 , 2010
Link: https://doi.org/10.1111/..
 
?
6

Practicalities in running early-phase trials using the time..:

van Werkhoven, Erik ; Hinsley, Samantha ; Frangou, Eleni...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477911/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
7

Improved pharmacodynamic (PD) assessment of low dose PARP i..:

de Haan, Rosemarie ; Pluim, Dick ; van Triest, Baukelien...
de Haan , R , Pluim , D , van Triest , B , van den Heuvel , M , Peulen , H , van Berlo , D , George , J , Verheij , M , Schellens , J H M & Vens , C 2018 , ' Improved pharmacodynamic (PD) assessment of low dose PARP inhibitor PD activity for radiotherapy and chemotherapy combination trials ' , Radiotherapy and Oncology , vol. 126 , no. 3 , pp. 443-449 . https://doi.org/10.1016/j.radonc.2017.10.017.  , 2018
Link: https://research.vumc.nl..
 
?
8

Improved pharmacodynamic (PD) assessment of low dose PARP i..:

de Haan, Rosemarie ; Pluim, Dick ; van Triest, Baukelien...
0167-8140.  , 2018
Link: https://dspace.library.u..
 
?
9

Retinal arteriolar geometry is associated with cerebral whi..:

Doubal, Fergus N ; de Haan, Rosemarie ; MacGillivray, Thomas J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3489044.  , 2010
Link: http://www.ncbi.nlm.nih...
 
?
10

Practicalities in running early-phase trials using the time..:

Erik van Werkhoven ; Samantha Hinsley ; Eleni Frangou...
http://link.springer.com/article/10.1186/s12874-020-01012-z.  , 2020
Link: https://doi.org/10.1186/..
 
?
11

Phase I feasibility study of Olaparib in combination with l..:

Arash Navran ; Abrahim Al-Mamgani ; Hester Elzinga...
http://www.sciencedirect.com/science/article/pii/S2405630823001234.  , 1481
Link: https://doi.org/10.1016/..
 
?
12

The AMC Linear Disability Score (ALDS): a cross-sectional s..:

Met, Rosemarie ; Reekers, Jim A ; Koelemay, Mark JW..
Health and Quality of Life Outcomes.  7 (2009)  1 - p. , 2009
Link: https://doi.org/10.1186/..
 
?
13

Clinical spectrum of individuals with pathogenic NF1 missen..:

Koczkowska, Magdalena ; Callens, Tom ; Chen, Yunjia...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6973139/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
?
14

A recurrent 16p12.1 microdeletion suggests a two-hit model ..:

Girirajan, Santhosh ; Rosenfeld, Jill A ; Cooper, Gregory M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2847896.  , 2010
Link: http://www.ncbi.nlm.nih...
 
?
15

A recurrent 16p12.1 microdeletion supports a two-hit model ..:

Girirajan, Santhosh ; Rosenfeld, Jill A ; Cooper, Gregory M...
qt89w1x55x.  , 2010
Link: https://escholarship.org..
 
1-15